Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Myelodysplastic syndrome with single lineage dysplasia
ADR ID BADD_A10463
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.04      Myelodysplastic syndromes
16.01.04.013      Myelodysplastic syndrome with single lineage dysplasia
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.04      Myelodysplastic syndromes
01.10.04.013      Myelodysplastic syndrome with single lineage dysplasia
Description A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy. [MeSH]
MedDRA Code 10088025
MeSH ID D000753
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anemia refractory | Refractory anaemia | Refractory anemia | Anaemia refractory | Refractory cytopenia with unilineage dysplasia | Myelodysplastic syndrome with single lineage dysplasia | Anemia, Refractory | Refractory Anemia | Anemias, Refractory | Refractory Anemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00194Azacitidine0.000112%
BADD_D00551Cyclosporine0.000221%
BADD_D00854Etoposide0.000168%
BADD_D01253Lenalidomide0.000482%
BADD_D01313Lomustine--
BADD_D01653Paclitaxel0.000168%
BADD_D01933Ribavirin0.007912%
BADD_D01954Rivaroxaban0.000127%
The 1th Page    1    Total 1 Pages